Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

Presentation TCT 2025

Controversial Management of LAAC Complications: Device Related Thrombus and Peri-Device Leaks

Presenter: Devi G. Nair

October 28, 2025

Watchman, Amulet LAAO Devices Have Similar Leak Rates at About 1 Year

News Conference News TCT 2023

Watchman, Amulet LAAO Devices Have Similar Leak Rates at About 1 Year

October 25, 2023

TCT 712: Device Related Thrombus Following Watchman FLX Placement for Left Atrial Appendage Occlusion: A Meta-Analysis of Pooled Incidence and Clinical Outcomes

Presentation TCT 2023

TCT 712: Device Related Thrombus Following Watchman FLX Placement for Left Atrial Appendage Occlusion: A Meta-Analysis of Pooled Incidence and Clinical Outcomes

Presenter: Aakash Garg

October 24, 2023

TCT 363: Incidence and timing of device related thrombus in percutaneous implantable cardiac devices: A systematic review and meta-analysis

Presentation TCT 2022

TCT 363: Incidence and timing of device related thrombus in percutaneous implantable cardiac devices: A systematic review and meta-analysis

Presenter: Richard Jung

September 19, 2022

LAAC Device Surveillance: Significance of Peri-Device Leaks and Device-Related Thrombus

Presentation TCT 2022

LAAC Device Surveillance: Significance of Peri-Device Leaks and Device-Related Thrombus

Presenter: Saibal Kar

September 19, 2022

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

News Conference News TCT 2022

Amulet, Watchman 2.5 LAAO Devices Provide Comparable 3-Year Outcomes

September 18, 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

News Conference News TCT 2022

Dedicated Catheter for Acute PE Shows Promise in IDE Trial

September 17, 2022

PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term

News Conference News TCT 2021

PRAGUE-17: LAA Occlusion Noninferior to DOACs Over Longer Term

November 05, 2021

LAA Closure Feasible in Patients With Thrombus: Registry

News Conference News TCT 2021

LAA Closure Feasible in Patients With Thrombus: Registry

Michael O'Riordan

October 13, 2021

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

News Conference News TCT 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

October 04, 2019

Critical Appraisal of Post-LAA Closure Pharmacology and Device-Related Thrombus

Presentation TCT 2019

Critical Appraisal of Post-LAA Closure Pharmacology and Device-Related Thrombus

Presenter: Kishore Harjai

September 27, 2019

Device-Related Thrombus: Mechanisms, Management, and Implications for Device Design

Presentation TCT 2019

Device-Related Thrombus: Mechanisms, Management, and Implications for Device Design

Presenter: Simon Cheung-chi Lam

September 27, 2019

Novel LAA Closure Device Shows Promise in Early Experience

News Conference News TCT 2018

Novel LAA Closure Device Shows Promise in Early Experience

September 22, 2018

TCT-102: Incidence, Predictors and Outcomes of Device-Related Thrombus After Left Atrial Appendage Closure With The WATCHMAN Device. Insights From the EWOLUTION Real World Registry

Presentation TCT 2018

TCT-102: Incidence, Predictors and Outcomes of Device-Related Thrombus After Left Atrial Appendage Closure With The WATCHMAN Device. Insights From the EWOLUTION Real World Registry

Presenter: Sameer Gafoor, David R. Holmes Jr., Alexander Sedaghat

September 21, 2018

Medical Treatment After LAA Closure: Trade-off of Bleeding vs Device-Related Thrombus

Presentation TCT 2017

Medical Treatment After LAA Closure: Trade-off of Bleeding vs Device-Related Thrombus

Presenter: Matthew J. Price, Jacqueline Saw, Lucas V. Boersma

October 31, 2017

News Conference News TCT 2012

Two Trials Examine Device-Based PFO Closure

October 25, 2012

Video

» Interview

AMULET IDE: One-Year Device Closure and Device-Related Thrombus Outcomes From a Randomized Trial of Amulet versus Watchman for Left Atrial Appendage Occlusion

November 5, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.